Cluster randomised controlled trial of specialist-led integrated COPD care (INTEGR COPD)

Thorax. 2024 Feb 15;79(3):209-218. doi: 10.1136/thorax-2023-220435.

Abstract

Objective: Studies in hospital settings demonstrate that there is greater guideline adherence when care is delivered by a respiratory specialist, however, this has not been explored in primary care. The aim of this study is to determine the impact integrating respiratory specialists into primary care has on the delivery of guideline adherent chronic obstructive pulmonary disease (COPD) care.

Methods: 18 general practitioner (GP) practices were randomised to provide either usual or specialist-led COPD care. Patients at participating practices were included if they had an existing diagnosis of COPD. Outcomes were measured at the individual patient level. The primary outcome was guideline adherence, assessed as achieving four or more items of the COPD care bundle. Secondary outcome measures included quality of life, number of exacerbations, number of COPD-related hospitalisations and respiratory outpatient attendances.

Results: 586 patients from 10 practices randomised to the intervention and 656 patients from 8 practices randomised to the control arm of the study were included. The integration of respiratory specialists into GP practices led to a statistically significant (p<0.001) improvement in the provision of guideline adherent care when compared with usual care in this cohort (92.7% vs 70.1%) (OR 4.14, 95% CI 2.14 to 8.03).

Conclusion: This is the first study to demonstrate that guideline adherence is improved through the integration of respiratory specialists into GP practices to deliver annual COPD reviews. To facilitate changes in current healthcare practice and policy, the findings of this paper need to be viewed in combination with qualitative research exploring the acceptability of specialist integration.

Trial registration number: NCT03482700.

Keywords: COPD Exacerbations; COPD epidemiology.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Delivery of Health Care
  • General Practice*
  • Humans
  • Pulmonary Disease, Chronic Obstructive*
  • Quality of Life

Associated data

  • ClinicalTrials.gov/NCT03482700